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Attendance at Counseling Sessions Predicts Good Treatment 
Response in Methadone Maintenance Therapy
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ABSTRACT
Objective: This study aimed to identify the predictors of good response in Methadone Maintenance Therapy (MMT) defined 
as retention and negative urine for opiate for 6 month after the enrollment.
Methods: Across-sectional study from October 2007 to March 2008 was conducted on injecting drug users (IDUs) in the 
MMT programme at the Psychiatric Clinic, Hospital Raja Perempuan Zainab II (HRPZ II).
Results: A total of 150 patients were studied. Good treatment response in MMT was seen in 55% of these patients. The only 
predictor of good treatment response in multivariate analyses was number of counseling sessions. For every increase in counsel­
ing sessions, a person has 1.2 times the chance of having a good outcome (Cl 1.049-1.349, p-value 0.007). Educational level, occu­
pation, marital status, age and maintenance dose were not significantly associated with response in MMT
Conclusion: Frequent attendance at counseling sessions was found to have a positive influence in the good treatment 
response in methadone therapy. Hence, it is an important component in the treatment of patients in MMT programme.
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INTRODUCTION
In Malaysia the response to illicit drug use has been largely puni­
tive. Nevertheless there has been a substantial rise in the number of drug 
users with over two-thirds of HIV/A1DS cases are among IDUs. High 
risk drug use practices are widespread and there has been an exponential 
rise in the number of cases reported. Harm reduction initiatives have 
only recently been introduced in Malaysia. In 2005 the government 
announced it will allow methadone maintenance programme to operate 
beyond the pilot phase to serve the needs of IDUs1’.
Previous studies have highlighted methadone maintenance doses2'71 
abstinence6-*1 and counseling attendance81 as important predictors o f good 
treatm ent outcom e. O ther predictor o f  better treatm ent response 
includes older age which has been hypothesized to result from increas­
ing dissatisfaction with the addict life style with advancing age51. 
Married patients had a better outcome probably due to support obtained 
from spouse and their sense of responsibility towards their family91. 
Moreover, patients who were already a parent on enrolment had a sig­
nificantly longer cumulative retention in treatment compared to those 
without children61.
The effectiveness of methadone maintenance treatment in reducing 
opiate use, related crime and HIV risk behaviors is well documented10111. 
Nonetheless, many patients drop out o f treatment or continue using opi­
ates and other illicit drugs. Significant treatment drop-outs typically 
occur in the first weeks or months of treatment121. Therefore, early iden­
tification of such patients could facilitate the development of treatment 
policy and guidelines targeted to their needs to prevent such incident.
This study aimed to identify the predictors o f good MMT treatment 
response defined as retention in the programme and no positive urinaly­
sis result throughout the 6-month study duration.
METHODS
The MMT programme in HRPZ II started in November 2005 after 
screening of 164 candidates with the first session of direct observation 
intake involving 25 patients performed on 13th November 2005. Patients 
with known mental illness were excluded from the study as they have 
been found to have poor treatment response131. Those receiving anti-ret­
roviral therapy were also excluded as anti-retroviral therapy was known 
to increase methadone metabolism thereby reducing its potency141.
The study was approved by the Research and Ethics Committee, 
Universiti Sains Malaysia and Ministry of Health. All patients who were 
still in the MMT programme and had completed the 6-month duration 
from enrollment before or within the study duration were identified. 
Two patients who died due to HIV related illness and another who were 
transferred to other MMT centre were excluded. In total, 150 eligible 
MMT patients were studied during the study period.
Most o f the socio-demographic and clinical data were collected 
from the clinical records. The Opiate Treatment Index151 which consists 
o f six independent outcome domains including drug use, HIV risk-tak­
ing behavior, social functioning, criminality, health status and psycho­
logical adjustment was routinely administered on enrollment into MMT 
programme. Additionally, a total of 7 urine samples were collected from
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Table 1. Characteristics of all patients and according to treatment response Table 2. Logistic Regression Analysis to Determine 
in MMT Factors Associated with good treatment
All subjects Good treatment Poor treatment _  response in MMT
(n =  150) response (n = 82) response (n = 68) p value Simple Logistic Multiple Logistic
Frequency (%) Frequency (%) Frequency (%) Regression Regression
Sex Crude OR P value Crude OR P
Male 149 (99.3) 81 (98.8) 68(100) 0.547* (95% Cl) (95% Cl) value
Female 1 (0.7) 1(1.2) 0(0) Educational 0.400 0.299 3.755 0.155
Ethnicity level (0.071,2.254) (0.606, 23.250)
Malay 148 (98.7) 82(100) 66 (97.1) 0.204* Occupation 1.185 0.660 1.250 0.590
Non-Malay 2(1.3) 0(0) 2(2.9) status (0.555, 2.529) (0.555, 2.816)
District Marital status 0.991 0.983 1.185 0.696
Kota Bharu 128 (85.3) 71(86.6) 57 (83.8) 0.634' (0.448, 2.193) (0.506, 2.776)
Others 22(14.7) 11 (13.4) 11 (16.2) Legal issue 1.526 0.345 0.508 0.159
Educational level (0.635, 3.666) (0.198, 1.304)
Primary school and 6 (4.0) 2 (2.4) 4(5.9) 0.257* Age 1.017 0.580 1.013 0.682
below (0.959, 1.079) (0.951, 1.079)
Secondary school and 144(96.0) 80 (97.6) 64(94.1) Maintenance 0.981 0.226 0.980 0.221
above dose (0.950, 1.012) (0.948, 1.012)
Occupational status Counselling 1.168 0.009 1.190 0.007
Unemployed 35 (23.3) 64 (78.0) 51 (75.0) 0.660’ sessions (1.040, 1.313) (1.049, 1.349)
Employed 115 (76.7) 18(22.0) 17(25.0)
Marital status
Single or divorce 119(79.3) 65 (79.3) 54 (79.4) 0.983'
Married 18 (20.7) 17(20.7) 14 (20.6)
Family conflict
No conflict 91 (60.7) 44 (53.7) 47 (69.1) 0.054’
Conflict presen: 59 (39.3) 38 (46.3) 21 (30.9)
HIV status
Non-reactive 49 (32.7) 27 (32.9) 22 (32.4) 0.941'
Reactive 101 (67.3) 55 (67.1) 46 (67.6)
Legal issue
No 24(16.0) 11 (13.4) 13 (19.1) 0.343*
Yes 126 (84.0) 71 (86.6) 55 (80.9)
Mean (SD) Mean Mean
Age 32.99 (5.51) 33.22 32.72 0.583'
Induction dose 27.50 (6.78) 27.50 28.43 0.407'
Maintenance dose 41.13 (10.53) 40.18 42.28 0.226'
Number of counselling 3.19(3.24) 3.84 2.40 0.004'
sessions
* Fisher's exact test, 'Chi-square test, independent t-test
each patient and 12 counseling sessions was conducted per individual, 
group and family by the National Drug Agency staffs, counselors or 
medical officers within the 6-month period following the enrollment. 
Data that were not available or missing from the records were obtained 
by direct questioning by the first author who was involved in the MMT 
programme.
The data was analyzed using SPSS Version 17.0 for Windows. 
Descriptive analysis was used to describe the socio-demographic, meth­
adone dosage and counseling session data. Univariate analysis was car­
ried out to see the association between outcome (treatment response) 
and the independent variables. Chi-square test was used for categorical 
data and t-test was used for continuous data. Fischer's exact test was 
used if the assumption of chi-square test was not met. Significant level 
for all statistical analysis was set at 0.05. The relationship of significant 
and selected variables was later analyzed using the simple and multiple 
linear regression analysis.
RESULTS
The average age of the patients was 33 years old with maintenance 
dose for methadone 41 mg/day as shown in table 1. Almost all the
patients were Malay male educated up to secondary school. More than 
three quarters were single or divorced, employed and having legal issue. 
About two thirds of them were HIV positive. Positive urine test for opi­
ate was found in 52 (34.7%) patients and 23 (15.3%) patients discontin­
ued the treatment within 6 months of enrollment into MMT. In total, 68 
(45.3%) of patients were considered to have poor treatment response in 
MMT. None of the socio-demographic and clinical variables were sig­
nificantly different between good and poor responder except for number 
of counseling sessions attended.
A logistic regression analysis was performed to measure the influ­
ence of treatment variable and outcome. Covariates included in the anal­
ysis were educational level, occupational and marital status, legal issue, 
age, methadone maintenance dose and number of counseling sessions 
attended. In preliminary final model, the only significant variable was 
counseling sessions. For every increase in counseling sessions, a person 
has 1.190 times the chance of having a good outcome (Cl 1.049-1.349, 
p value 0.007)
D IS C U S S IO N
Of the 150 patients, 127 remain in the programme after 6 month of
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enrollment giving a retention rate of 84.7% which was quite good com­
pared to a local study conducted in University Malaya Medical Centre121 
which found 75% retention rate after 18 weeks of treatment. The reten­
tion rates tend to become lower as the duration of treatment become lon­
ger. A study in Germany l6,(Wittchen 2008) had a 12-month retention 
rate of 75%. Another local study conducted in Hospital Tengku Ampuan 
Afzan71 calculated a retention rate of 59.9% over a period of 2 years. 
Nevertheless, most of the drop out occurred early in the treatment 
before stabilization consistent with the study by Gill121, in which two- 
thirds of drop out occurred within the first month of treatment. 
Pertaining to the other part of treatment response, which is the urine test 
for opiate, 52 (34.7%) of patients were found to be positive mostly 
during the first few weeks of joining the therapy. It was rather not sur­
prising as it is during this period that the methadone dosage was still 
being adjusted to achieve the optimum dose. Only 82 (54.7%) patients 
with both negative urine tests and retention in therapy for 6 months 
duration were considered to have a good treatment response in this 
study
Average methadone maintenance doses of 60 to 120 mg or higher 
have consistently better results than use of lower average doses, espe­
cially because heroin purity is now often greater than 40%171. However, 
the mean maintenance dose in this study was 41.1 mg which was com­
parable to 45 mg daily dose of methadone in another local study by 
Gill121. The authors argued that this was either because of the low quality 
of heroin, frequently containing less than 10% heroin or the different 
genetic make-up of our ethnic groups, as compared to the Caucasian 
population. Interesting a study conducted in Minneapolis'81 showed that 
ethnic Hmong from Laos required lower doses of methadone for stabili­
zation (M = 49.0 vs. 77.1 mg; p < .0001) compared to heroin-addicted 
non-Hmong comprising mostly of Caucasian (50%) and African 
American (38%). This study did not find significant difference in meth­
adone maintenance dose between the poor and good responders with the 
mean maintenance dose of 42.3 mg and 40.2 mg respectively. This indi­
cates that there were other more important factors that contributed to 
poor response to treatment.
Counseling was the only variable found to have a significant associ­
ation with treatment response in this study. A study by Morral81 conclud­
ed that participants who attended 2 counseling sessions by the end of the 
second week of treatment were more than 12 times as likely to have 
superior 9 months outcome. It was suggested that counseling plays a 
synergistic role in treatment response in addition to the dosage of meth­
adone. Methadone alone, even in substantial doses, may only be effec­
tive for a minority of patients. The addition of basic counseling was 
associated with major increase in efficacy and the addition of on-site 
professional services was even more effective191. Attendance to counsel­
ing served as an indicator of those patients with greater motivation or 
treatment compliance, each of which could contribute to superior treat­
ment response.
CONCLUSION
In conclusion, counseling attendance is the only significant predic­
tor for good treatment response defined as retention and negative urine 
test for opiate for 6 months after the enrollment in MMT. This study 
emphasizes the significance of provider related variables for enhancing
treatment response rather than the patient's socio-demographic back­
ground.
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